Hiba El Hajj

12PUBLICATIONS
30CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Host-parasite interactionsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 26, 2025
Retinoic acid disrupts an NPM1c/ROS/SENP3/ARF oncogenic axis in acute myeloid leukemia.

Rita Hleihel, Hala Skayneh, Hsin-Chieh Wu

|May 28, 2025
Exploring the Anti-Leukemic Effect of the Synthetic Retinoid ST1926 on Malignant T Cells: A Comprehensive Proteomics Approach.

Mona Goli, Vishal Sandilya, Botheina Ghandour

|May 28, 2025
The Novel Imiqualine EAPB02303 Is a Potent Drug for Treating Acute Myeloid Leukemia.

Perla Makhoul, Rita Hleihel, Shaymaa Itani

|Jan 15, 2025
The Toxoplasma rhoptry protein ROP55 is a major virulence factor that prevents lytic host cell death.

Margarida T Grilo Ruivo, Ji-Hun Shin, Todd Lenz

|Dec 17, 2024
Direct Interaction Between CD34+ Hematopoietic Stem Cells and Mesenchymal Stem Cells Reciprocally Preserves Stemness.

Rémi Safi, Tala Mohsen-Kanson, Farah Kouzi

|Jul 27, 2024
Uncovering the Molecular Pathways Implicated in the Anti-Cancer Activity of the Imidazoquinoxaline Derivative EAPB02303 Using a Caenorhabditis elegans Model.

Perla Makhoul, Simon Galas, Stéphanie Paniagua-Gayraud

Pageof 2

Frequent Collaborators

3 joint publications

Pierre-Antoine Bonnet

2 joint publications

Perla Makhoul

2 joint publications

Simon Galas

2 joint publications

Myriam Richaud